Skip to main navigation Skip to search Skip to main content

The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

  • Kristine Griffett
  • , Ryan D. Welch
  • , Colin A. Flaveny
  • , Grant R. Kolar
  • , Brent A. Neuschwander-Tetri
  • , Thomas P. Burris
  • Saint Louis University

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)353-357
Number of pages5
JournalMolecular Metabolism
Volume4
Issue number4
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Molecular Biology
  • Cell Biology

Keywords

  • Fibrosis
  • Inflammation
  • Lipogenesis
  • LXR
  • NASH

Fingerprint

Dive into the research topics of 'The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis'. Together they form a unique fingerprint.

Cite this